Skip to main content
. 2022 Jan 15;2022:7178711. doi: 10.1155/2022/7178711

Figure 1.

Figure 1

The levels of tumor markers in the two groups of patients before and after treatment. (a) The comparison of the VEGF levels of the two groups of patients before and after treatment. (b) The comparison of the BTA levels of the two groups of patients before and after the treatment.